Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 19/20 | 0.65 |
| ▸ | CA2 | P00918 | 19/20 | 0.65 |
| ▸ | CA9 | Q16790 | 16/20 | 0.65 |
| ▸ | CA7 | P43166 | 3/20 | 0.48 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23598950 | 0.92 | CA1 (0.64) | CA1CA2CA9CA7CA13 | |
| SCHEMBL23598888 | 0.90 | CA1 (0.53) | CA1CA2CA9CA7CA13 | |
| SCHEMBL23599046 | 0.89 | CA1 (0.52) | CA1CA2CA9CA7CA13 | |
| SCHEMBL23598890 | 0.88 | CA1 (0.50) | CA1CA2CA9CA7CA13 | |
| SCHEMBL23599244 | 0.85 | CA1 (0.47) | CA1CA2CA9CA7CA13 | |
| SCHEMBL23599339 | 0.85 | CA1 (0.59) | CA1CA2CA9CA7CA13 | |
| SCHEMBL23599177 | 0.82 | CA1 (0.56) | CA1CA2CA9CA7CA13 | |
| SCHEMBL23599346 | 0.81 | CA1 (0.49) | CA1CA2CA9CA7CA13 | |
| SCHEMBL23598976 | 0.81 | CA1 (0.67) | CA1CA2CA9CA7CA13 | |
| SCHEMBL23599215 | 0.81 | CA1 (0.62) | CA1CA2CA9CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021133915-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) MODULATORS AND USES THEREOF | Sanford Burnham Prebys Medical Discovery Institute (US) | 2021-07-01 | — | — | WO | disclosed |